BEAT THE STREET GAME:
Tony Coles' tenure got off to the right start with strong earnings and meaningful financial guidance.
Onyx Pharma Swings to Outsized Profit
The biotech company trounces Wall Street expectations for the first quarter on sales gains of Nexavar.
05/06/08 - 05:09 PM EDT
Monday's Winners & Losers: Yahoo!
Shares fall 15% after the company's buyout by Microsoft falls apart.
05/05/08 - 04:37 PM EDT
Kass: Buffett Gets a Free Pass
Berkshire Hathaway traffics in derivatives -- instruments of which Buffett has consistently been critical.
05/05/08 - 11:59 AM EDT
Discovery Labs Holds Out Hope for Surfaxin
The stock Monday regains some of its sharp Friday losses on the company's positive response to FDA delays. But is the reaction overly optimistic?
05/05/08 - 11:53 AM EDT
Getting bullish on Melco Entertainment, General Dynamics and Time Warner, plus much more.
05/04/08 - 10:25 AM EDT
Weekend Reading: Goodbye Microhoo!
Gauging how far Yahoo! shares will fall, plus much more required financial reading.
05/04/08 - 02:16 PM EDT
Feuerstein's Biotech-Stock Mailbag
Outlooks for SuperGen's Dacogen and Myriad Genetics' Flurizan; more Q&A on ImClone's Erbitux, and more.
05/03/08 - 11:10 AM EDT
Bristol Sells ConvaTec Unit for $4.1 Billion
A group of pricate equity firms is buying the wound care business in a deal expected to close in the third quarter.
05/02/08 - 04:54 PM EDT
Friday's Winners & Losers: Yahoo!
Shares rise 6.9% on more merger rumors.
05/02/08 - 04:25 PM EDT
FDA Approval Delay Sinks Discovery Labs
Surfaxin receives an approvable letter, but the additional delays that accompany it send shares plummeting in premarket trading.
05/02/08 - 08:22 AM EDT
Altucher: End-of-the-World Stocks
James Altucher describes winning stocks for a doomed planet.
05/01/08 - 11:52 AM EDT
symbol throughout our site to look up items.
